Skip to Content

Weather update: The Columbia campus will have a delayed opening until 10 am tomorrow, Jan. 18. This applies to all offices. Classes scheduled to begin before 10 am are canceled. Classes scheduled to begin at or after 10 am will take place as scheduled. See sc.edu/weather for updates See sc.edu/weather for updates.

College of Pharmacy


Cancer Research

Cancer researchers in the College of Pharmacy study the molecular basis of cancer — from understanding the pathways and cellular changes that accompany cancer to specific gene mutations that drive the disease.

Cancer is a collection of diseases involving many tissues of the body. All cancers result from abnormal cell growth and proliferation, and many cancers have the potential to spread to other parts of the body (metastasis).

In 2016 there will be an estimated 1,685,210 new cancer cases diagnosed and 595,690 cancer deaths in the US.

Source: American Cancer Society

Our faculty perform studies that identify new cellular targets for cancer drugs (targeted therapeutics), discover and develop new drugs, and identify new ways of delivering drugs specifically to cancer cells. We use state-of-the-art methodologies and pharmacogenomic approaches to explore DNA mutations and gene expression in individual tumors, to identify the best chemotherapeutic drug to treat cancer patients and improve the effectiveness of cancer treatment and overall outcome.